(Q80553646)
Statements
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1 (English)
Carl D Regillo
David M Brown
Prema Abraham
Huibin Yue
Tsontcho Ianchulev
Susan Schneider
1 February 2008